Clinical trial
Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients
NCT00043758
Study timeline
Study start (unknown)2002-07-01Date precision: month
Registry last updated2005-06-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Congestive Heart Failureunresolved
Interventions
TolvaptanDRUG · verified · RxNorm: tolvaptan
Sponsors & collaborators
Mapped research locations
TorontoOntario, Canada2DetroitMichigan, United States2ProvidenceRhode Island, United States2New YorkNew York, United States1PhiladelphiaPennsylvania, United States1MiamiFlorida, United States1CincinnatiOhio, United States1San DiegoCalifornia, United States1ColumbusOhio, United States1IndianapolisIndiana, United States1DenverColorado, United States1New HavenConnecticut, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00043758 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.